Maintenance Therapy in Myeloma with Dr. Hira Mian and Dr. Manni Mohyuddin
ฝัง
- เผยแพร่เมื่อ 15 ก.ย. 2024
- In this episode, we dive into the data on maintenance therapy in multiple myeloma with Dr. Hira Mian and Dr. Manni Mohyuddin. Here are the key studies we discussed:
1. Meta-analysis of individual patient-level data from CALGB, IFM, and Italian maintenance RCTs (lenalidomide vs placebo or observation):
pubmed.ncbi.nl...
2. Myeloma XI RCT (lenalidomide vs observation): pubmed.ncbi.nl...
3. Outcomes of lenalidomide maintenance stratified by cytogenetic subgroups (Secondary analysis of Myeloma XI): pubmed.ncbi.nl...
4. Canadian real-world data on lenalidomide maintenance: pubmed.ncbi.nl...
5. FORTE trial (Carfilzomib-Lenalidomide vs Lenalidomide): pubmed.ncbi.nl...
6. ATLAS trial (Carfilzomib-Lenalidomide-Dexamethasone vs Lenalidomide): pubmed.ncbi.nl...
7. Differential censoring and potential impact on PFS in ATLAS trial: pubmed.ncbi.nl...
8. GEM2014 (Ixazomib-Lenalidomide-Dexamethasone vs Lenalidomide-Dexamethasone): ashpublication...
9. MASTER trial (MRD-guided treatment de-escalation): pubmed.ncbi.nl...
10. Outcomes after MRD-guided treatment discontinuation (Secondary analysis of GEM2014MAIN trial): pubmed.ncbi.nl...